Taiko Pharmaceutical Co.,Ltd. (TYO:4574)

Japan flag Japan · Delayed Price · Currency is JPY
291.00
-7.00 (-2.35%)
At close: Jan 21, 2026
-6.43%
Market Cap14.62B
Revenue (ttm)5.94B
Net Income (ttm)853.00M
Shares Out50.25M
EPS (ttm)16.98
PE Ratio17.13
Forward PE55.43
Dividendn/a
Ex-Dividend Daten/a
Volume244,800
Average Volume133,500
Open298.00
Previous Close298.00
Day's Range290.00 - 298.00
52-Week Range228.00 - 444.00
Beta0.25
RSI44.25
Earnings DateFeb 13, 2026

About Taiko Pharmaceutical

Taiko Pharmaceutical Co.,Ltd. manufactures and sells over-the-counter (OTC) medicines in Japan and internationally. The company provides OTC medicines for the treatment of loose stools, diarrhea, vomiting, food and water poisoning symptoms, and toothache; and quasi-drugs for regulation of intestinal movements, relieves stomach distention, loose stools, and constipation. It manufactures and sells infection control products. Taiko Pharmaceutical Co.,Ltd. exports its products. The company was incorporated in 1946 and is headquartered in Osaka, Jap... [Read more]

Sector Healthcare
Founded 1946
Employees 214
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4574
Full Company Profile

Financial Performance

Financial Statements